| 20.08.2024 08:56 | AZN | TOP NEWS: AstraZeneca asthma drug Fasenra gets approval in China | Alliance |
| 19.08.2024 09:31 | AZN | AstraZeneca and Daiichi Sankyo gets US and European nods for Enhertu | Alliance |
| 16.08.2024 08:27 | AZN | AstraZeneca's Infinzi gets US approval for treatment of lung cancer | Alliance |
| 16.08.2024 07:00 | AZN | Imfinzi approved in US for resectable lung cancer | RNS |
| 15.08.2024 08:56 | AZN | TOP NEWS: AstraZeneca's Imfinzi secures US priority review for cancer | Alliance |
| 14.08.2024 09:16 | SHEL, AZN | TOP NEWS: AstraZeneca celebrates EU approval of Lynparza plus Imfinzi | Alliance |
| 13.08.2024 11:38 | AZN | AstraZeneca and Daiichi Sankyo get new approval in China for Enhertu | Alliance |
| 01.08.2024 15:00 | AZN | Total Voting Rights | RNS |
| 01.08.2024 14:32 | VSVS, ULVR, TMI | UK dividends calendar - next 7 days | Alliance |
| 30.07.2024 15:59 | AZN | IN BRIEF: AstraZeneca prices EUR1.4 billion in bonds at 3.1% and 3.3% | Alliance |
| 30.07.2024 07:00 | AZN | AstraZeneca prices a €1.4bn bond offering | RNS |
| 29.07.2024 15:37 | AZN | Astra's breast cancer drug not recommended for NHS use due to price | Alliance |
| 29.07.2024 09:39 | NWG, HSBA, SGRO | LONDON BROKER RATINGS: Citigroup lifts BAE; Morgan Stanley cuts Drax | Alliance |
| 29.07.2024 08:37 | AZN | AstraZeneca reports positive findings from ongoing leukaemia trial | Alliance |
| 26.07.2024 15:27 | AZN, STX, TTG | EXECUTIVE CHANGES: Morgan Advanced Materials picks senior director | Alliance |
| 26.07.2024 13:27 | AZN | IN BRIEF: Astra pushes to get Imfinzi approved for lung cancer in US | Alliance |
| 26.07.2024 09:43 | REL, ULVR, AZN | LONDON BROKER RATINGS: Greencore and Hammerson cut to 'hold' | Alliance |
| 26.07.2024 07:00 | AZN | ODAC reviewed Imfinzi in resectable lung cancer | RNS |
| 25.07.2024 09:37 | AZN | TOP NEWS: AstraZeneca shares fall despite improved full-year outlook | Alliance |
| 25.07.2024 07:00 | AZN | Half-year Report | RNS |
| 19.07.2024 15:32 | VOD, ULVR, REL | UK earnings, trading statements calendar - next 7 days | Alliance |
| 18.07.2024 16:07 | VOD, WKP, ULVR | UK earnings, trading statements calendar - next 7 days | Alliance |
| 15.07.2024 07:00 | AZN | Acquisition of Amolyt Pharma completed | RNS |
| 10.07.2024 10:08 | IPX, LIO, GFM | LONDON BROKER RATINGS: Barclays raises Kerry, cuts Hunting, Wood Group | Alliance |
| 05.07.2024 08:36 | AZN | TOP NEWS: AstraZeneca drug Tagrisso gets EU approval for cancer form | Alliance |
| 03.07.2024 09:57 | AZN, APTA | Aptamer shares jump as inks agreement with AstraZeneca | Alliance |
| 02.07.2024 09:47 | III, SDR, PRU | LONDON BROKER RATINGS: Deutsche Bank cuts Quilter, ups Polar Capital | Alliance |
| 01.07.2024 15:00 | AZN | Total Voting Rights | RNS |
| 01.07.2024 09:13 | AZN | TOP NEWS: AstraZeneca cancer and Covid drugs recommended for approval | Alliance |
| 01.07.2024 07:00 | AZN | Lynparza & Imfinzi positive CHMP in endometrial | RNS |
| 26.06.2024 08:40 | AZN | TOP NEWS: AstraZeneca's Tagrisso plus chemo gets approval in China | Alliance |
| 25.06.2024 09:05 | AZN | TOP NEWS: AstraZeneca details mixed findings from cancer drug trials | Alliance |
| 25.06.2024 07:05 | AZN | Update on Imfinzi ADJUVANT BR.31 trial | RNS |
| 25.06.2024 07:00 | AZN | Imfinzi improved EFS and OS in bladder cancer | RNS |
| 20.06.2024 10:56 | AZN | TOP NEWS: AstraZeneca's Truqap gets OK from EU for breast cancer form | Alliance |
| 18.06.2024 09:33 | AZN | TOP NEWS: AstraZeneca disappointed by breast cancer drug trial results | Alliance |
| 18.06.2024 07:00 | AZN | Update on CAPItello-290 Phase III trial | RNS |
| 17.06.2024 09:09 | AZN | TOP NEWS: Astra's Imfinzi plus chemo approved for cancer form in US | Alliance |
| 17.06.2024 07:23 | AZN | IN BRIEF: AstraZeneca gets positive cancer test results for Calquence | Alliance |
| 17.06.2024 07:00 | AZN | Imfinzi approved in the US for endometrial cancer | RNS |
| 12.06.2024 20:56 | AZN | AstraZeneca's Farxiga approved to treat paediatric type-2 diabetes | Alliance |
| 12.06.2024 15:00 | AZN | Director/PDMR Shareholding | RNS |
| 10.06.2024 09:10 | AZN, DGE, LAND | LONDON BROKER RATINGS: JPMorgan cuts Aviva but lifts M&G | Alliance |
| 10.06.2024 08:30 | AZN | TOP NEWS: Astra's Tagrisso gets US priority review for lung cancer | Alliance |
| 05.06.2024 09:52 | AWE, GLE, ECOR | LONDON BROKER RATINGS: Berenberg raises Taylor Wimpey to 'buy' | Alliance |
| 05.06.2024 09:27 | AZN | AstraZeneca completes USD2.4 billion Fusion Pharmaceuticals purchase | Alliance |
| 05.06.2024 07:00 | AZN | Acquisition of Fusion completed | RNS |
| 03.06.2024 15:05 | AZN | Block listing Interim Review | RNS |
| 03.06.2024 15:00 | AZN | Total Voting Rights | RNS |
| 03.06.2024 08:59 | AZN | AstraZeneca cancer treatment Tagrisso recommended for approval in EU | Alliance |
| 03.06.2024 07:00 | AZN | Tagrisso plus chemo recommended for approval in EU | RNS |
| 30.05.2024 09:23 | PSON, LGEN, BATS | LONDON BROKER RATINGS: Jefferies and UBS cut Anglo American | Alliance |
| 29.05.2024 08:54 | AZN | IN BRIEF: AstraZeneca drug lowers cholesterol in phase 1 trial | Alliance |
| 28.05.2024 07:00 | AZN | Dato-DXd improved OS in nonsquamous lung cancer | RNS |
| 27.05.2024 07:49 | AZN | IN BRIEF: Astra, Daiichi hail positive survival data for Dato-DXd | Alliance |
| 22.05.2024 09:53 | ETL, BOKU, ATYM | LONDON BROKER RATINGS: Barclays cuts NextEnergy but lifts JLEN | Alliance |
| 21.05.2024 08:18 | AZN | TOP NEWS: AstraZeneca eyes new era of growth with bold new revenue aim | Alliance |
| 21.05.2024 07:00 | AZN | AstraZeneca to deliver $80bn revenue by 2030 | RNS |
| 20.05.2024 08:24 | AZN | TOP NEWS: AstraZeneca plans to build manufacturing plant in Singapore | Alliance |
| 20.05.2024 07:00 | AZN | AstraZeneca to manufacture ADCs in Singapore | RNS |
| 16.05.2024 10:27 | AZN | AstraZeneca trials yield positive results for immunocompromised patients | Alliance |
| 16.05.2024 07:00 | AZN | SUPERNOVA Trial Met COVID-19 prevention endpoint | RNS |
| 15.05.2024 15:00 | AZN | Director/PDMR Shareholding | RNS |
| 08.05.2024 09:44 | AZN | AstraZeneca says withdraws Covid vaccine "for commercial reasons" | Alliance |
| 08.05.2024 09:39 | FDEV, BOO, CAL | LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral | Alliance |
| 07.05.2024 09:51 | AIBG, BIRG, S32 | LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered | Alliance |
| 07.05.2024 07:00 | AZN | AstraZeneca completes Cellectis equity investment | RNS |
| 06.05.2024 07:46 | AZN | AstraZeneca completes collaboration and investment deal with Cellectis | Alliance |
| 03.05.2024 12:17 | AZN, AGL | CORRECT: Angle shares up on assay development deal with AstraZeneca | Alliance |
| 03.05.2024 11:50 | AZN, AGL | Angle shares up on assay development deal with AstraZenaca | Alliance |
| 02.05.2024 10:04 | AZN | AstraZeneca notes positive trial results for Calquence treatment | Alliance |
| 02.05.2024 07:00 | AZN | Calquence combination improved PFS in 1L MCL | RNS |
| 01.05.2024 15:00 | AZN | Total Voting Rights | RNS |
| 29.04.2024 10:02 | MTC, BOO, MOTR | LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD | Alliance |
| 29.04.2024 09:13 | AZN | AstraZeneca makes progress with Truqap and Enhertu cancer treatments | Alliance |
